UNIVERSITY OF KARACHI
🇵🇰Pakistan
- Country
- 🇵🇰Pakistan
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.uok.edu.pk
Bioequivalence Study of Klaribact 125mg/5ml, Suspension
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Drug: Klaricid 125mg/5ml SuspensionDrug: Klaribact 125mg/5ml Suspension
- First Posted Date
- 2022-04-22
- Last Posted Date
- 2022-04-29
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 24
- Registration Number
- NCT05340452
- Locations
- 🇵🇰
Center for Bioequivalence Studies and clinical research (CBSCR), ICCBS, Karachi, Sindh, Pakistan
Bioequivalence Study of Levomerc 500 mg Tablets
- First Posted Date
- 2022-04-21
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 24
- Registration Number
- NCT05339295
- Locations
- 🇵🇰
Center for Bioequivalence Studies and clinical research (CBSCR), ICCBS, Karachi, Sindh, Pakistan
Effects of Cardamom and Fennel on Salivary pH and Anti Microbial Activity
Not Applicable
Completed
- Conditions
- Electrolyte DisturbanceSaliva Altered
- Interventions
- Biological: cardamomBiological: fennel
- First Posted Date
- 2022-02-17
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 50
- Registration Number
- NCT05245019
- Locations
- 🇵🇰
Altamash Institute of Dental Medicine, Karachi, Sindh, Pakistan
Left Atrial Appendage (LAA) Clot With Severe Mitral Stenosis
- Conditions
- Left Atrial Appendage AneurysmMitral Stenosis
- Interventions
- Other: WARFARIN
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2022-01-11
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 52
- Registration Number
- NCT05186649
- Locations
- 🇵🇰
Karachi Institute of Heart Disease, Karachi, Sindh, Pakistan
Educational Intervention for Hypertension Management
Not Applicable
- Conditions
- Hypertension
- Interventions
- Other: Printed Education MaterialOther: Face to face Educational Training
- First Posted Date
- 2021-09-09
- Last Posted Date
- 2021-09-17
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 126
- Registration Number
- NCT05038774
- Locations
- 🇵🇰
Karachi institute of heart disease, Karachi, Sindh, Pakistan
Bioequivalence Study of Anplag® 90mg (Ticagrelor) Tablet & Brilinta® 90 mg (Ticagrelor) Tablet in Healthy Adult Male Pakistani Subjects Under Fasting Condition
Phase 1
Completed
- Conditions
- Healthy Individuals
- Interventions
- First Posted Date
- 2021-06-28
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 30
- Registration Number
- NCT04941196
- Locations
- 🇵🇰
Center for Bioequivalence Studies and clinical research, Karachi, Sindh, Pakistan
Bioequivalence of Lamnet (Lamotrigine)100mg Tablet With the Reference Product Lamictal 100mg (Lamotrigine) Tablet Under Fasting Conditions
- First Posted Date
- 2021-06-24
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 26
- Registration Number
- NCT04938856
- Locations
- 🇵🇰
Center for Bioequivalence Studies and clinical research, Karachi, Sindh, Pakistan
Comparative Effects of Metformin and Insulin on Stereological Studies and Immunohistochemistry of Placenta
Not Applicable
Completed
- Conditions
- Diabetes Mellitus in PregnancyDiabetes Mellitus Arising in Pregnancy, Insulin-Requiring
- Interventions
- First Posted Date
- 2021-06-01
- Last Posted Date
- 2021-06-01
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 156
- Registration Number
- NCT04907708
- Locations
- 🇵🇰
Jinnah Post Graduate Medical Centre, Karachi, Sindh, Pakistan
Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.
- First Posted Date
- 2021-05-07
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 60
- Registration Number
- NCT04877834
- Locations
- 🇵🇰
Center for Bioequivalence Studies and clinical research, Karachi, Sindh, Pakistan
Bioequivalence Study of Mofest® 400mg (Moxifloxacin) Tablet With Avelox® 400mg (Moxifloxacin) Tablet in Healthy Pakistani Subjects
Phase 1
Completed
- Conditions
- Bioequivalence StudyHealthy Individuals
- Interventions
- First Posted Date
- 2021-05-05
- Last Posted Date
- 2022-09-07
- Lead Sponsor
- University of Karachi
- Target Recruit Count
- 38
- Registration Number
- NCT04873570
- Locations
- 🇵🇰
Center for Bioequivalence Studies and clinical research, Karachi, Sindh, Pakistan
© Copyright 2025. All Rights Reserved by MedPath